BSE filing, NSE: RKSWAMY. Summary written from the filing by ALFA Finder's alert engine.
R K Swamy Ltd: key numbers
- Share price
- ₹78.00
- Market cap
- ₹393.7 Cr
- Revenue (annual)
- ₹340.8 Cr
- Net profit (annual)
- ₹22.11 Cr
- P/E (TTM)
- 17.4×Sector 28.6×
- Promoter holding
- 69.61%+0.00% QoQ
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from R K Swamy Ltd
All →R K Swamy Other Announcement
R K Swamy Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine disclosure.
R K Swamy Other Announcement
R K Swamy Ltd filed the mandatory Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, as issued by its RTA, KFin Technologies Limited.
R K Swamy Annual General Meeting
R K Swamy Ltd concluded its 53rd Annual General Meeting, approving the audited financial statements and a final dividend of Rs. 2 per share.
R K Swamy Other Announcement
R K Swamy filed the Monitoring Agency Report for the quarter ended June 30, 2026. The report provides a status update on IPO proceeds utilization.
R K Swamy Results Update
R K Swamy Limited announced Q1 FY27 financial results, reporting consolidated revenue of ₹86 Crore and profit before tax of ₹4.6 Crore.
R K Swamy Investor Presentation: Key Takeaways
R K Swamy reported solid Q1 FY27 results with consolidated income and PBT growth, focusing on margin expansion through operating leverage and new high-value consulting and digital content streams.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.